US Pre-Market SEC Filings Roundup — August 24, 2026

24-08-2026

Rainier Acquisition Corp filed an S-1/A registration statement for its initial public offering of units consisting of Class A ordinary shares and warrants. The offering will involve up to 7,694,375 units, with each unit containing one-quarter of one redeemable warrant exercisable at $11.50 per share. The sponsor, Ravenna 7 LLC, and key officers and directors are identified, and the filing details various redemption scenarios, underwriting arrangements, and expense structures.

• · The units will automatically separate into their component parts after the initial business combination and will not be traded thereafter.
• · Separate trading of Class A ordinary shares and warrants is prohibited until a Current Report on Form 8-K with an audited balance sheet is filed.
• · No fractional warrants will be issued upon separation of units; only whole warrants will trade.
• · The exercise price of warrants may be adjusted to 115% of the higher of Market Value and Newly Issued Price under certain conditions.
• · The redemption trigger price for warrants may be adjusted to 165% of the higher of Market Value and Newly Issued Price under certain conditions.

24-08-2026

X Financial (XYF) filed a Form 6-K with the SEC on August 24, 2026, reporting its second quarter 2026 unaudited financial results. The filing includes the earnings release as Exhibit 99.1. No specific financial figures are provided in the cover page, so a balanced assessment of performance cannot be made from this excerpt alone.

• · The filing is a Form 6-K for the month of August 2026.
• · The registrant is X Financial, a foreign private issuer, with its principal executive offices in Shenzhen, China.
• · The filing is signed by Yue (Justin) Tang, Chairman and CEO.
• · The company files annual reports under Form 20-F.

24-08-2026

Li Auto Inc. filed a Form 6-K on August 24, 2026, which attaches four Next Day Disclosure Returns dated August 17-20, 2026. The filings are routine disclosures under Hong Kong listing rules; no financial or operational results are reported.

• · Filing date: August 24, 2026
• · Exhibits: Next Day Disclosure Returns for August 17, 18, 19, and 20, 2026
• · The returns likely relate to share buybacks or changes in issued shares, which are routine for Hong Kong-listed companies

24-08-2026

Alibaba Group announced a proposed placing of new shares in Hong Kong, initially disclosed on August 24, 2026, and subsequently priced at HK$80 billion (approximately $10.3 billion). The placement is being conducted under a general mandate, indicating a significant equity capital raise.

• · The filing includes four exhibits: two press releases and two announcements with the Stock Exchange of Hong Kong Limited, covering the proposal and pricing of the placing.
• · The placing is under a general mandate, suggesting shareholder authorization for such issuances.

24-08-2026

Modiv Industrial, Inc. filed Form 15 to terminate its SEC registration and suspend its duty to file reports under the Exchange Act, effective August 24, 2026, following its merger into GNL Motion Merger Sub, LLC (a subsidiary of Global Net Lease, Inc.) on August 12, 2026. As of the filing date, the company had zero holders of record for both its Class C Common Stock and its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, reflecting the completion of the merger. The deregistration is a routine procedural step after the acquisition, with no ongoing reporting obligations remaining.

• · The merger was completed on August 12, 2026, under an Agreement and Plan of Merger dated May 3, 2026.
• · The surviving entity in the merger is GNL Motion Merger Sub, LLC.
• · The Form 15 relies on Rule 12g-4(a)(1) and Rule 12h-3(b)(1)(i) to terminate/suspend reporting duties.
• · No other classes of securities remain subject to reporting under Section 13(a) or 15(d).

24-08-2026

Magnum Ice Cream Co B.V. (MICC) disclosed a series of share purchases from August 18 to August 21, 2026, for its Long Term Incentive Plans, totaling 1,359,487 ordinary shares at an aggregate cost of approximately €22.78 million. The purchases were executed across three venues: Euronext, CBOE DXE, and Turquoise Europe, with the highest volume on Euronext each day. The filing is a routine disclosure of share buyback activity for employee incentive plans, with no negative or flat metrics to report.

• · The average daily purchase price ranged from €16.45689 to €16.949 over the four days.
• · The largest single-day purchase was on 19 August 2026 with 406,707 shares at €6,799,266.62.
• · Euronext was the primary venue each day, accounting for 829,174 shares (61% of total) over the period.
• · CBOE DXE and Turquoise Europe accounted for 420,492 and 109,821 shares respectively.

24-08-2026

Aegon Ltd. announced a EUR 150 million increase to its second-half 2026 share buyback program, bringing the total program to EUR 350 million from EUR 200 million. The increase is consistent with Aegon's objective to reduce Cash Capital at Holding to around EUR 1.0 billion by year-end 2026. However, as of the announcement date, only EUR 57 million (approximately 28% of the initial EUR 200 million program) had been repurchased, indicating that the majority of the buyback remains to be executed.

• · The expanded program is expected to be completed by December 23, 2026.
• · Aegon has entered into an agreement with its largest shareholder, Vereniging Aegon, to participate in the additional EUR 150 million.
• · Vereniging Aegon will participate pro-rata based on its 18.4% shareholding.
• · The number of common shares to be repurchased from Vereniging Aegon will be determined based on the daily volume-weighted average price on Euronext Amsterdam.
• · Aegon intends to cancel the shares repurchased under this program.
• · The buyback will be executed in compliance with the EU Market Abuse Regulation and within existing shareholder authority granted on June 10, 2026.

24-08-2026

Tencent Holdings Ltd filed a Schedule 13D/A with the SEC on August 24, 2026, disclosing that it ceased to be a beneficial owner of more than 5% of Amer Sports, Inc. ordinary shares as of August 20, 2026. Tencent now holds 15,794,146 ordinary shares (2.7% of total outstanding), down from a prior stake above 5%. The filing indicates a significant reduction in Tencent's ownership position in Amer Sports.

• · Tencent's holdings consist of 13,871,069 shares held by Huang River Investment Limited and 1,923,077 shares held by Bright Adventure Holding Limited.
• · No transactions in ordinary shares were effected by Tencent or related persons during the past 60 days.
• · The filing is an amendment (Schedule 13D/A) to a prior Schedule 13D.

24-08-2026

Aveanna Healthcare Holdings Inc. filed a prospectus supplement for a secondary offering of 15,000,000 shares of common stock by selling stockholders, including affiliates of Bain Capital and J.H. Whitney Capital Partners. The public offering price is $11.75 per share, with total proceeds to selling stockholders of $172.5 million. The company will not receive any proceeds from the offering. Following the offering, Aveanna will no longer be a controlled company under Nasdaq rules, though its sponsors will continue to have significant influence. The offering price of $11.75 represents a discount from the last reported sale price of $13.16 on August 21, 2026.

• · The offering is a secondary sale; Aveanna receives no proceeds.
• · Underwriter has a 30-day option to purchase up to an additional 2,250,000 shares from Whitney Selling Stockholders.
• · Following the offering, Aveanna will no longer be a controlled company under Nasdaq rules, but sponsors will retain significant influence.
• · Aveanna completed the acquisition of Family First Holding, LLC on June 1, 2026, a multi-state pediatric home care provider.
• · The company's segments are Private Duty Services, Home Health & Hospice, and Medical Solutions.

24-08-2026

AITX announced that its RAD-M product has been rebranded as PURSUON, advancing the company's autonomous mobile security strategy. The filing is a routine 8-K furnishing a press release under Item 8.01 and does not contain any financial results or material operational changes.

• · The press release is titled 'AITX's RAD-M Becomes PURSUON, Advancing the Company's Autonomous Mobile Security Strategy'.
• · The filing is dated August 24, 2026, and was signed by CEO Steven Reinharz.

24-08-2026

On August 21, 2026, a jury in the U.S. District Court for the District of Delaware returned a mixed verdict in the patent infringement action brought by Beckman Coulter against Cytek Biosciences. The jury found in Cytek's favor on three of the four asserted patent claims (noninfringement and invalidity) but found infringement on one claim under the doctrine of equivalents, awarding Beckman Coulter $20 million in lost profits and $36.11 million in royalties. Cytek intends to pursue post-verdict motions and potential appeals to challenge that finding and the damages award.

• · The jury found no literal infringement on all four claims but found infringement under the doctrine of equivalents on one claim.
• · Cytek intends to pursue post-verdict motions challenging the infringement finding and damages award.
• · The company may also appeal to the United States Court of Appeals for the Federal Circuit.
• · No period-over-period comparisons are provided as the filing contains only a single event date.

24-08-2026

Fortress Private Lending Fund disclosed an unregistered sale of 309,338 Class I common shares for aggregate consideration of $7.5 million in August 2026, with the purchase price based on the July 31, 2026 NAV of $24.2066 per share. The company also declared a monthly distribution of $0.1834 per share for August 2026, payable on September 22, 2026. As of July 31, 2026, the fund's aggregate NAV was approximately $1.1 billion, with a portfolio of $1.9 billion across 91 companies, 98.2% in first-lien floating-rate debt, and $884.9 million in debt outstanding.

• · The unregistered sale was made under Section 4(a)(2) of the Securities Act and Regulation D to accredited investors.
• · The August 2026 distribution of $0.1834 per share will be paid on September 22, 2026 to shareholders of record as of August 31, 2026.
• · The portfolio's directly originated debt investments had a median EBITDA of $81.6 million and interest coverage of 2.8x.
• · No established public market exists for the company's shares.
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.

24-08-2026

ConnectM Technology Solutions, Inc. (CNTM) reported a net income of $12.75M for Q2 2026, a significant turnaround from a net loss of $4.80M in Q2 2025, driven largely by a $19.05M gain on disposal of discontinued operations. Revenue grew 24.2% YoY to $9.79M in Q2 2026, but gross profit margin declined from 36.5% to 28.6% due to a 39.7% increase in cost of revenues. The company's net loss from continuing operations narrowed to $1.17M from $7.03M in the prior year quarter, though operating cash flow remained negative at -$4.59M for the first half of 2026.

• · Goodwill decreased from $5.22M to $2.60M, a 50.1% reduction, primarily due to disposal of discontinued operations.
• · Investment in equity securities of $33.73M and investment in equity method investee of $7.83M were newly recorded as of June 30, 2026, reflecting the Sun Solar and Blue Cloud transactions.
• · Total liabilities increased to $37.18M from $34.59M, driven by a $5.46M increase in accrued expenses and other current liabilities and a $3.46M increase in debt.
• · Basic and diluted net loss per share from continuing operations improved to -$0.21 in Q2 2026 from -$3.98 in Q2 2025.
• · The company recorded a $2.31M gain from change in fair value of investment in equity securities in Q2 2026.
• · Interest expense surged to $844,128 in Q2 2026 from $85,757 in Q2 2025, a 884% increase.
• · Selling, general and administrative expenses decreased 15.9% YoY to $5.40M in Q2 2026 from $6.42M in Q2 2025.
• · A $322,616 loss on impairment of intangible assets was recognized in Q2 2026.
• · The company had a net cash used in operating activities of -$4.59M for H1 2026, slightly worse than -$4.31M in H1 2025.
• · Proceeds from issuance of debt and convertible notes totaled $8.06M in H1 2026, compared to $4.29M in H1 2025.

24-08-2026

Super League Enterprise, Inc. increased the maximum aggregate offering price of its common stock under an existing Sales Agreement with The Benchmark Company and StoneX Financial by an additional $2,270,000. Approximately $2,228,999 of shares had already been sold under the agreement. The filing relates to a prospectus supplement and legal opinion filed as exhibits.

24-08-2026

Holtec Nuclear Corp filed an S-1/A registration statement for its IPO. For the six months ended June 30, 2026, total revenue was $269.9M, down 5.8% from $286.6M in the prior-year period, while net income rose to $205.6M from a prior-year loss of $39.8M, driven by a $202.2M realized gain on investments. The Palisades segment reported a $39.8M operating loss with no revenue, and the company had $1.5B in remaining performance obligations as of June 30, 2026.

• · The Palisades segment had no revenue and an operating loss of $39.9M for the six months ended June 30, 2026.
• · Palisades restart work in process (capitalized) increased from $1.14B at Dec 31, 2025 to $1.63B at June 30, 2026.
• · Long-term DOE receivable for spent fuel, net of allowance, was $648.8M at June 30, 2026, up from $635.4M at Dec 31, 2025.
• · Allowance for cost adjustments on DOE receivable was $437.0M at June 30, 2026, up from $422.2M at Dec 31, 2025.
• · Inventories declined 23.1% from $26.6M to $20.5M, driven by decreases in raw materials and finished goods.
• · Accrued expenses and other current liabilities fell 21.4% from $261.8M to $205.7M, primarily due to lower vendor accruals and advance from customers.
• · Depreciation expense surged to $45.0M in H1 2026 from $11.4M in H1 2025, reflecting the expanded asset base.
• · The company had no allowance for credit losses on accounts receivable as of June 30, 2026 or Dec 31, 2025.
• · The company expects to recognize 24% of remaining performance obligations within 12 months and 76% thereafter, mostly over three years.
• · The company recorded a $202.2M realized gain on investments and a $43.9M unrealized loss on investments in H1 2026.
• · The nuclear decommissioning trust (NDT) fund balance was $2.84B at June 30, 2026, exceeding the ARO of $1.63B.
• · The company is party to a standard contract with the DOE for spent nuclear fuel disposal; DOE is expected to begin accepting fuel in 2041.

24-08-2026

Columbus Circle Capital Corp II (CMII) filed a 425 communication in connection with its proposed business combination with Elroy Air, Inc., which will result in the combined entity being renamed Inflection Point Acquisition Corp. VII. The filing includes social media posts from Elroy Air announcing a major milestone: its Chaparral heavy cargo drone was selected as the only pure-play large cargo drone for the FAA's IP (Integration Pilot) program, selected by the White House, Department of Transportation, and FAA, and is beginning initial flights in Louisiana. The business combination is subject to shareholder approval and SEC review, with a registration statement on Form S-4 confidentially submitted.

• · The Chaparral drone packs down into a trailer for stowage and transport.
• · Elroy Air is partnering with Bristow Group for the IP program flights.
• · The business combination will be submitted to IPAC shareholders for a vote; a definitive proxy statement will be mailed after the registration statement is declared effective.
• · The filing includes standard forward-looking statements and risk factors, including that the demand pipeline consists of non-binding letters of intent and MOUs.

24-08-2026

CalSTRS filed its quarterly 13F-HR for the period ending June 30, 2026, reporting a portfolio of over $108.6 billion in U.S. equity securities. The fund's largest holdings include Apple Inc. ($22.3B), Amazon.com Inc. ($14.7B), AT&T Inc. ($10.7B), and Bank of America Corp. ($10.3B), reflecting a diversified, large-cap focused strategy. The filing provides a snapshot of holdings as of mid-2026, with no period-over-period comparisons available in the document.

• · The filing includes 3,002 distinct securities, indicating a highly diversified portfolio.
• · Top 10 holdings by value: Apple ($22.3B), Amazon ($14.7B), AT&T ($10.7B), Bank of America ($10.3B), Alphabet Class A ($8.8B), Alphabet Class C ($7.0B), Microsoft (implied large), NVIDIA (implied large), Meta (implied large), and Tesla (implied large).
• · The fund holds significant positions in major tech, financial, healthcare, and energy companies, consistent with a passive/index-oriented strategy.
• · No period-over-period comparisons are available in this filing, as it is a snapshot of holdings as of June 30, 2026.

24-08-2026

Zeo Energy Corp. filed a universal shelf registration statement on Form S-3 with the SEC on August 21, 2026, to register the offer and sale of up to $150,000,000 in securities (common stock, preferred stock, debt securities, warrants, rights, and units) in one or more future offerings. The filing does not disclose any specific offering terms, use of proceeds, or current financial results, and it contains extensive risk factors related to the company's business, industry, and market conditions.

• · The registration statement was filed under the Securities Act of 1933, as amended, and is a shelf registration (Form S-3).
• · The company may offer common stock, preferred stock, debt securities, warrants, rights, and units, individually or in combination.
• · The filing includes a cautionary note regarding forward-looking statements and lists numerous risk factors, including competition, supply chain disruptions, changes in government incentives for renewable energy, and geopolitical conflicts.
• · The company was formerly known as ESGEN Acquisition Corp and changed its name on June 2, 2021.
• · The filing does not include any specific offering details, pricing, or use of proceeds beyond the general shelf registration.

24-08-2026

On August 19, 2026, Roman DBDR Acquisition Corp. II (DRDBU, DRDB, DRDBW) received a Nasdaq deficiency notice for failing to maintain a minimum of 400 public holders required by Listing Rule 5450(a)(2). The company has until October 5, 2026, to submit a compliance plan, with a possible extension to February 15, 2027; failure could lead to delisting. The notice has no immediate effect on listing.

• · The deficiency relates to Nasdaq Global Market listing standard requiring at least 400 holders.
• · If the compliance plan is rejected, the company can appeal to a Nasdaq Hearings Panel.

24-08-2026

Suzano S.A. filed a Form 6-K with the SEC for August 2026, attaching the minutes of a Board of Directors' meeting. The filing was signed by Vice-President of Finance and Investor Relations Marcos Moreno Chagas Assumpção. No specific financial results, strategic actions, or performance metrics were disclosed in the filing itself.

• · The filing is a routine report of a foreign private issuer under Rule 13a-16 or 15d-16.
• · The attached exhibit is the minutes of the Board of Directors' meeting.
• · The filing date is August 24, 2026, and the report is for the month of August 2026.

24-08-2026

Sigma Lithium Corporation filed a Form 6-K with the SEC on August 24, 2026, attaching a press release dated August 21, 2026. The filing is a routine foreign issuer report and does not contain any financial results or material operational updates.

• · Filing is a Form 6-K for the month of August 2026.
• · Commission File Number: 001-40786.
• · Address: 181 Bay Street, Suite 4400, Toronto, Ontario, M5J 2T3, Canada.
• · Company files annual reports under Form 40-F.
• · Press release dated August 21, 2026 is attached as Exhibit 99.1 but its content is not included in this filing excerpt.

24-08-2026

Presidio Property Trust, Inc. filed Amendment No. 1 to its Schedule TO, amending the exchange offer originally filed on August 7, 2026. The company is offering to exchange each outstanding share of its 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock for 5.5 newly issued shares of Series A Common Stock. As of August 6, 2026, there were 973,736 shares of Series D Preferred Stock outstanding. The Series D Preferred Stock has experienced significant price volatility over the past two years, with a high of $15.99 and a low of $3.65 in recent quarters, and the company is not making any recommendation to holders regarding the exchange.

• · The Series D Preferred Stock is listed on Nasdaq under symbol 'SQFTP'.
• · High and low sales prices for Series D Preferred Stock ranged from $15.99 (Q4 2025 high) to $3.65 (Q1 2026 low) over the past two years.
• · No transactions in Series D Preferred Stock were effected by the company or its insiders in the past 60 days.
• · The company is not making any recommendation to holders regarding the exchange offer.
• · The exchange offer is subject to conditions set forth in the prospectus dated August 21, 2026.

24-08-2026

SVP Estrada Ingrid A sold 2,000 Common Stock at $314.66 (~$629K). Estrada Ingrid A holds 103,861.19 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · SVP Estrada Ingrid A sold 2,000 Common Stock at $314.66 (~$629K)

24-08-2026

Chief Executive Officer Liu Chang acquired 2,837 American depositary shares at $2.46 (~$6.97K). 5 transactions reported in total. Liu Chang holds 75,849 shares after the transaction.

• · Chief Executive Officer Liu Chang acquired 221 American depositary shares at $2.40 (~$529)
• · Chief Executive Officer Liu Chang acquired 294 American depositary shares at $2.28 (~$670)
• · Chief Executive Officer Liu Chang acquired 572 American depositary shares at $2.26 (~$1.29K)
• · Chief Executive Officer Liu Chang acquired 2,837 American depositary shares at $2.46 (~$6.97K)
• · Chief Executive Officer Liu Chang bought 846 American depositary shares at $2.46 (~$2.08K)

24-08-2026

ZTO Express (Cayman) Inc. filed a Form 6-K with the SEC for August 2026, attaching five Next Day Disclosure Returns dated August 18–24, 2026. The filing is a routine foreign issuer report signed by CFO Huiping Yan, with no financial results or material events disclosed.

• · The filing includes five Next Day Disclosure Returns dated August 18, 19, 20, 21, and 24, 2026.
• · The report is signed by Huiping Yan, Chief Financial Officer.

24-08-2026

On August 19, 2026, a U.S. District Court in California issued a mixed ruling in multiple cases involving Sable Offshore Corp. The court found that Sable violated a 2020 consent decree by restarting pipeline operations without state authorization, imposing a $1.449 million penalty, but declined to order a shutdown because PHMSA had since approved the restart plan. The court also upheld a Defense Production Act order that preempts state law barriers to pipeline operations, providing Sable with key legal wins, though the State of California and other defendants have filed appeals.

• · The court granted the U.S. motion to substitute PHMSA for OSFM as the regulatory authority overseeing pipeline operations under the consent decree.
• · The court denied the U.S. motion to terminate the consent decree.
• · In California v. Wright, the court denied California's motion for a preliminary injunction against the DPA Order, finding California failed to show 'even serious questions on the merits.'
• · In Sable v. Quintero, the court declared the DPA Order bars California Parks from preventing Sable from operating the onshore SYPS; the case is closed.
• · In CBD v. CDFFP, the court remanded the case to state court but noted the DPA Order preempts state laws that would burden Sable's compliance.
• · California filed a notice of appeal on August 20, 2026, and the defendant in Sable v. Quintero filed a notice of appeal on August 21, 2026.

24-08-2026

Ecovyst Inc. announced the appointment of Laurie Bergman as Chief Financial Officer, effective August 24, 2026, replacing Michael Feehan, who will depart the company. Ms. Bergman brings extensive finance leadership experience from previous CFO roles at Legacy Food Group and Liquid Environmental Solutions. Mr. Feehan will remain with the company until September 30, 2026, to ensure a smooth transition. No financial impact was disclosed.

• · Laurie Bergman, 49, previously served as CFO of Legacy Food Group since July 2024, and CFO of Liquid Environmental Solutions from June 2021 to June 2024.
• · Ms. Bergman served as Chief Accounting Officer, Corporate Controller and VP Accounting of UGI Corporation from February 2019 to June 2021.
• · Ms. Bergman has been a board member and audit committee chair of Arq, Inc. since June 2023, and a board member and audit committee member of QNB Corp. since May 2020.
• · Michael Feehan will continue as an employee until September 30, 2026, to facilitate a smooth transition.

24-08-2026

Callan JMB Inc. (CJMB) entered into a definitive Asset Purchase Agreement to acquire oil and gas assets in the Williston Basin from Reger Oil, Inc. for a total consideration of $12M, comprising $10M in Series A Perpetual Convertible Preferred Stock and $2M in cash. The transaction is expected to close by September 22, 2026, subject to customary conditions including Nasdaq stockholder approval, and includes governance changes such as the appointment of Michael Reger to the board. No prior-period financial data is provided, so period-over-period comparisons are not available.

• · The APA may be terminated if closing does not occur by October 31, 2026.
• · Seller's fundamental representations survive indefinitely; other reps survive 12 months post-closing.
• · Assets acquired on 'as is, where is' basis with special warranty of defensible title.
• · Transaction is structured as an asset purchase, not a business acquisition for Regulation S-X purposes.
• · Preferred Stock issuance is exempt from registration under Section 4(a)(2) of the Securities Act.
• · A current director will resign post-closing, and Preferred Stock holders will nominate a replacement.

24-08-2026

Toppoint Holdings Inc. has postponed its 2026 Annual Meeting of Stockholders from August 24 to September 8, 2026, to give stockholders more time to receive and review proxy materials and submit votes. No changes have been made to the record date, meeting location, or proposed agenda. The postponement is a procedural matter with no financial impact disclosed.

• · Original meeting date: August 24, 2026, 10:00 a.m. ET
• · New meeting date: September 8, 2026, 10:00 a.m. ET
• · Record date: August 7, 2026 (unchanged)
• · Meeting format: Virtual via live webcast at www.virtualshareholdermeeting.com/TOPP2026 (unchanged)
• · A revised proxy card reflecting the postponed date accompanies the notice.

24-08-2026

Zhihu Inc. filed a Form 6-K with the SEC for August 2026, attaching five Next Day Disclosure Returns dated August 17–21, 2026. The filing is a routine regulatory submission by the CFO, with no financial results or material business developments disclosed.

• · The filing includes five Next Day Disclosure Returns covering consecutive days from August 17 to August 21, 2026.
• · No financial figures, operational metrics, or forward-looking statements are provided in the filing.

24-08-2026

BRC Inc. (BRCC) filed a Certificate of Amendment to effect a 1-for-10 reverse stock split of its Class A Common Stock, effective August 21, 2026 at 5:01 p.m. Eastern Time. No fractional shares will be issued; instead, holders of fractional shares will receive a cash payment based on the proceeds from aggregated fractional share sales. The amendment was adopted under Section 242 of the Delaware General Corporation Law.

• · Reverse stock split ratio: 1-for-10 (each 10 shares of Class A Common Stock become 1 share)
• · Effective time: 5:01 p.m. Eastern Time on August 21, 2026
• · No fractional shares will be issued; fractional interests will be cashed out via aggregated open market sale
• · Amendment filed under Section 242 of the Delaware General Corporation Law

24-08-2026

Endeavour Silver Corp. filed a Form 6-K with the SEC for August 2026, attaching a press release dated August 23, 2026. The filing does not contain specific financial figures, but the press release likely covers quarterly or annual results. No quantitative data or performance comparisons are provided in the filing itself.

• · Filing is a Form 6-K for the month of August 2026.
• · Commission File Number: 001-33153.
• · Exhibit 99.1 is a press release dated August 23, 2026.
• · Registrant's address: #1130-609 Granville Street, Vancouver, British Columbia, Canada V7Y 1G5.
• · Registrant files annual reports under Form 40-F.

24-08-2026

KLX Energy Services Holdings, Inc. commenced a subscription rights offering on August 24, 2026, allowing eligible holders to purchase shares at $1.49 per share, with each right entitling the holder to buy 3.885 shares. The offering expires on September 23, 2026, and the company intends to use up to $31.0 million of gross proceeds for fees and general corporate purposes, with any excess used to repurchase 2030 Notes at par plus accrued interest. The rights will trade on Nasdaq under the symbol 'KLXER' until expiration.

• · The Rights Offering is being made under an existing shelf registration statement on Form S-3 (Reg. No. 333-295905).
• · Eligible Holders include holders of Common Stock and holders of outstanding warrants issued on March 12, 2025, March 6, 2026, and March 11, 2026.
• · The Record Date for the Rights Offering was August 21, 2026.
• · The company entered into a Rights Offering Backstop Agreement with holders of the 2030 Notes, as disclosed in an August 10, 2026 Form 8-K.
• · No fractional shares will be issued; all exercises will be rounded down to the nearest whole share.
• · The subscription rights will trade on Nasdaq under the symbol 'KLXER' from August 24, 2026, until the Expiration Date.

24-08-2026

This SEC Form 6-K filing by GSK plc provides updated contact information for its media and investor relations teams. The filing does not contain any financial results, business developments, or material events.

24-08-2026

Ermenegildo Zegna N.V. filed a Form 6-K with the SEC on August 24, 2026, furnishing a press release. The filing discloses no financial data or qualitative commentary beyond the cover page; no quantitative or comparative metrics are provided.

• · The 6-K filing includes only a press release as Exhibit 99.1, dated August 24, 2026.
• · No financial results, segment performance, or forward-looking statements are contained in the filing body.

24-08-2026

Extra Space Storage Inc. (EXR) announced a CEO succession: President Noah Springer will become CEO effective January 1, 2027, succeeding Joe Margolis, who will retire at year-end 2026 and serve as a Board adviser. The transition was unanimously approved by the Board. Under Margolis's decade-long tenure, the company grew from ~1,400 stores to over 4,400 stores, market cap rose from ~$9B to $30B, and annual revenue more than tripled from $1.1B to $3.5B. However, the filing does not disclose any current financial performance metrics or near-term guidance, so no period-over-period comparisons are available.

• · Springer joined Extra Space in 2006 and became Chief Strategy and Partnership Officer in 2020; he was promoted to President on January 1, 2026.
• · Springer developed and leads the Management Plus platform, which has nearly 2,000 locations and is described as the storage sector's largest, fastest growing, and most profitable third-party management platform.
• · Margolis began working with Extra Space in 1998 via a joint venture, joined the Board in 2005, became CIO in 2015, and CEO in 2017.
• · Under Margolis, rentable square feet grew from ~100 million to more than 340 million.
• · Margolis oversaw the acquisition of Storage Express and the merger with Life Storage.
• · The company will attend the Self Storage Association Fall Conference (Sept 8-11, 2026, Las Vegas) and the BAML Global Real Estate Conference (Sept 15-16, 2026, NYC).

24-08-2026

Comstock Inc. (LODE) announced on August 24, 2026, that it has closed the sale of 100% of its mineral, mining, processing, and mining-district-related real estate entities to Mackay Precious Metals Inc., a wholly owned subsidiary of Mackay Gold & Silver Corp. (TSXV: MACK, OTCQB: MKGSF). This transaction represents a significant strategic shift for Comstock, divesting its mining-related assets. No financial terms of the deal or any comparative period performance metrics were disclosed in this filing.

• · The transaction closed on August 24, 2026.
• · The acquired entities include all of Comstock's mineral, mining, processing, and mining-district-related real estate holdings.
• · The acquirer, Mackay Precious Metals Inc., is a wholly owned subsidiary of Mackay Gold & Silver Corp.
• · No financial terms of the acquisition were disclosed in the filing.

24-08-2026

Utz Brands, Inc. has filed a preliminary proxy statement for a special meeting of stockholders to vote on a proposed 'going private' merger with entities affiliated with Intersnack Group GmbH & Co. KG. Under the agreement, each share of Class A Common Stock will be converted into the right to receive $14.25 per share in cash, representing a 91% premium over the closing price on July 20, 2026. The merger has been unanimously recommended by a Special Committee and the Board (with two directors abstaining), and key stockholders including Dylan Lissette, Timothy Brown, and the Rice Family Foundation have already agreed to vote in favor via a Voting Agreement.

• · The merger requires approval by a majority of outstanding Utz Common Stock (Majority Approval Voting Requirement) and a majority of votes cast by disinterested stockholders (Unaffiliated Stockholder Approval Voting Requirement).
• · Shares of Class V Common Stock will be canceled for no consideration.
• · Non-voting or failure to return a proxy will have the same effect as a vote 'AGAINST' the Transaction Proposal for the Majority Approval requirement but no effect for the Unaffiliated Stockholder requirement.
• · The proxy statement includes multiple annexes: Merger Agreement, Voting Agreement, Implementation Agreement, LLC Operating Agreement amendments, TRA Amendment, Purchase Agreement, and Redemption Agreement.

24-08-2026

XPENG INC. filed a Form 6-K on August 24, 2026, disclosing a discloseable transaction and connected transaction related to a subscription, the grant of redemption rights, and the adoption of the Dogotix 2026 Equity Incentive Plan. The filing indicates a strategic investment or acquisition involving Dogotix, with associated equity incentive arrangements. No specific financial figures or performance metrics were provided in the filing.

• · The transaction involves a subscription and grant of redemption rights, suggesting a structured investment or acquisition deal.
• · The Dogotix 2026 Equity Incentive Plan was adopted as part of the transaction.
• · The filing is classified as a discloseable transaction and connected transaction under relevant rules.

24-08-2026

News Corp filed an 8-K on August 24, 2026, to disclose its daily ASX reporting obligations under its existing $1 billion stock repurchase program. The filing reiterates the company's authorization to repurchase up to $1 billion in aggregate of its Class A and Class B common stock, but provides no new financial results or material operational updates.

• · The repurchase program covers both Class A common stock (ticker: NWSA) and Class B common stock (ticker: NWS).
• · The filing is a routine procedural update to comply with ASX daily disclosure rules; no actual repurchase transactions were reported in the 8-K itself.

24-08-2026

InterCure Ltd. announced it has finalized a NIS 230 million (approximately US $77 million) settlement for war-related indirect damages. The settlement is a significant event for the company, providing a large cash influx, though it arises from adverse war circumstances.

• · The settlement is for war-related indirect damages.
• · The press release was issued on August 24, 2026.
• · The report on Form 6-K was filed with the SEC for the month of August 2026.

24-08-2026

Philip Morris International Inc. announced on August 24, 2026, that it has entered into a contract manufacturing arrangement for combustible cigarettes with Philip Morris USA, an operating company of Altria Group Inc., through certain of its non-U.S. affiliates. The arrangement was disclosed via a press release furnished as Exhibit 99.1 to an SEC Form 8-K under Regulation FD. No financial terms, volumes, or performance metrics were disclosed in the filing.

• · The arrangement involves non-U.S. affiliates of PMI.
• · The filing is under Item 7.01 (Regulation FD Disclosure) and is not deemed 'filed' for SEC liability purposes.
• · No financial details, duration, or expected impact of the arrangement were provided.

24-08-2026

ANI Pharmaceuticals appointed Henry Gosebruch to its Board of Directors effective August 19, 2026, bringing over 30 years of corporate strategy and M&A experience from AbbVie and J.P. Morgan. Concurrently, director Muthusamy (Samy) Shanmugam resigned from the board but remains in his executive roles as Head of R&D and COO of New Jersey Operations. The appointments are intended to strengthen business development and capital allocation as ANI accelerates its transformation into a leading Rare Disease company.

• · Henry Gosebruch currently serves as CEO of Lakefront Biotherapeutics NV since May 2025 and is also a board member there.
• · Gosebruch previously served as President and CEO of Neumora Therapeutics from July 2023 to February 2025.
• · At AbbVie (2015-2023), he was EVP and Chief Strategy Officer, leading over 100 transactions including the Allergan acquisition.
• · Earlier career: over 20 years at J.P. Morgan, most recently as Co-Head of North American M&A.
• · Gosebruch holds a B.S. in Economics from Wharton and is a certified public accountant.
• · Samy Shanmugam resigned from the board effective immediately but remains in executive management as Head of R&D and COO of New Jersey Operations.
• · Shanmugam had served on the board for five years.

24-08-2026

Precision BioSciences announced the first patient has been dosed in its Phase 1/2 FUNCTION-DMD clinical trial evaluating PBGENE-DMD for Duchenne muscular dystrophy at Arkansas Children's Hospital. This milestone advances the company's gene-editing pipeline into the clinic for DMD, though no efficacy or safety data were disclosed and the trial remains early-stage.

• · Trial is Phase 1/2, evaluating PBGENE-DMD for Duchenne muscular dystrophy.
• · Dosing occurred at Arkansas Children's Hospital.
• · No financial terms, revenue impact, or enrollment targets were disclosed.
• · The filing is a Regulation FD disclosure and an Other Events item, not a material definitive agreement.

24-08-2026

BioXcel Therapeutics entered into the Thirteenth Amendment to its Credit Agreement with Oaktree Fund Administration LLC on August 21, 2026. The amendment extends the deadline for the company to enter into definitive agreements for a transaction that would repay all loan obligations or an alternative capital solutions transaction from August 21 to August 28, 2026. This indicates the company is under significant pressure to secure refinancing or a capital event within a very short timeframe.

• · The Thirteenth Amendment was entered into on August 21, 2026.
• · The original deadline under the Twelfth Amendment was August 21, 2026; the new deadline is August 28, 2026.
• · The required transaction must either repay all loan obligations under the Credit Agreement or be an alternative capital solutions transaction acceptable to the Lenders.

24-08-2026

YHN Acquisition I Ltd is seeking shareholder approval at its September 14, 2026 Annual Meeting to further extend its deadline to complete a business combination from September 19, 2026 to June 19, 2027 via three optional three-month extensions. The company, which entered into a Business Combination Agreement with Mingde Technology Limited on April 3, 2025, has already extended once from the original December 19, 2025 deadline and deposited $150,000 per extension in 2025 and early 2026. However, at the prior extension vote, 3,464,179 ordinary shares were tendered for redemption, indicating significant shareholder skepticism about the SPAC's prospects.

• · First extension deposit under the new proposal must be made on or before the Current Termination Date (Sep 19, 2026); subsequent deposits on or before each then-existing termination date.
• · The company has until Sep 19, 2026 under the current extension to complete a business combination.
• · Original IPO deadline was Dec 19, 2025 (15 months post-IPO closing on Sep 17, 2024).
• · The meeting will be held both in-person at Loeb & Loeb LLP, Hong Kong and virtually with provided dial-in details.
• · Record date for voting is August 19, 2026.

24-08-2026

Tiziana Life Sciences announced a poster presentation on its Phase 2a BANYAN clinical trial of intranasal foralumab in ALS at the ALS Nexus 2026 conference. The trial is in its operational start-up phase; no enrollment or efficacy data were disclosed. The announcement highlights the scientific rationale for targeting the Treg pathway in ALS but provides no new financial or material clinical results.

• · The BANYAN trial is a 3:1 (foralumab:placebo) randomized, placebo-controlled, multicenter Phase 2a study.
• · The trial is supported by a grant from the ALS Association and partially funded by the Martha Olson-Fernandez Foundation and the ALS Bridge Foundation.
• · The trial will assess safety, biomarkers of immune modulation and neuroinflammation (including PET imaging of microglial activation), and early signals of clinical effect.
• · The trial is currently in its operational start-up phase; enrollment timing and site locations will be provided in a forthcoming press release.
• · 14 patients with non-active secondary progressive multiple sclerosis (na-SPMS) have been dosed in an open-label Expanded Access Program with either improvement or stability of disease seen within 6 months in all patients.
• · Intranasal foralumab is also being studied in a Phase 2a, randomized, double-blind, placebo-controlled, multicenter, dose-ranging trial in na-SPMS (NCT06292923).